Company intelligence / Profile preview

ASCOPHARM NOVASCO Group

Nantes, France

Ownership: Private
Development stage: Other

Overview

Ascopharm Novasco Group is a French Contract Research Organization (CRO) providing comprehensive clinical research services to the pharmaceutical, biotechnology, and medical device industries. The group specializes in clinical trial management, regulatory affairs, pharmacovigilance, and biometrics. Founded in 1995, it established a strong reputation in the European market for its expertise in Phase I through Phase IV clinical trials. In 2019, the company was acquired by Aixial, the life sciences division of the Alten Group, to strengthen its service offerings and geographic reach. Today, the entity operates as part of Aixial's integrated clinical development platform, supporting global health product development.

Industry: Contract Research Organization

Beyond the preview

Go deeper on ASCOPHARM NOVASCO Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ASCOPHARM NOVASCO Group.

Explore the full profile